B

BioCryst Pharmaceuticals
D

BCRX

10.360
USD
-0.04
(-0.38%)
مغلق
حجم التداول
112,811
الربح لكل سهم
0
العائد الربحي
-
P/E
-40
حجم السوق
2,167,832,839
أصول ذات صلة
ALNY
ALNY
3.30
(1.08%)
308.00 USD
BNTX
BNTX
1.870
(1.78%)
106.710 USD
C
CRSP
0.050
(0.12%)
41.360 USD
E
EDIT
-0.20500
(-9.45%)
1.96500 USD
GILD
GILD
-2.080
(-1.86%)
110.010 USD
INCY
INCY
-1.490
(-2.15%)
67.750 USD
MRNA
MRNA
-0.670
(-2.45%)
26.680 USD
REGN
REGN
7.50
(1.44%)
529.39 USD
R
RGEN
-3.770
(-2.87%)
127.530 USD
VRTX
VRTX
-4.36
(-0.95%)
455.70 USD
المزيد
الأخبار المقالات

العنوان: BioCryst Pharmaceuticals

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.